Cargando…

The effect of treatment delay on time‐to‐recovery in the presence of unobserved heterogeneity

We study the effect of delaying treatment in the presence of (unobserved) heterogeneity. In a homogeneous population and assuming a proportional treatment effect, a treatment delay period will result in notably lower cumulative recovery percentages. We show in theoretical scenarios using frailty mod...

Descripción completa

Detalles Bibliográficos
Autores principales: van Geloven, Nan, Balan, Theodor A., Putter, Hein, le Cessie, Saskia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383985/
https://www.ncbi.nlm.nih.gov/pubmed/31957043
http://dx.doi.org/10.1002/bimj.201900131
_version_ 1783563530053615616
author van Geloven, Nan
Balan, Theodor A.
Putter, Hein
le Cessie, Saskia
author_facet van Geloven, Nan
Balan, Theodor A.
Putter, Hein
le Cessie, Saskia
author_sort van Geloven, Nan
collection PubMed
description We study the effect of delaying treatment in the presence of (unobserved) heterogeneity. In a homogeneous population and assuming a proportional treatment effect, a treatment delay period will result in notably lower cumulative recovery percentages. We show in theoretical scenarios using frailty models that if the population is heterogeneous, the effect of a delay period is much smaller. This can be explained by the selection process that is induced by the frailty. Patient groups that start treatment later have already undergone more selection. The marginal hazard ratio for the treatment will act differently in such a more homogeneous patient group. We further discuss modeling approaches for estimating the effect of treatment delay in the presence of heterogeneity, and compare their performance in a simulation study. The conventional Cox model that fails to account for heterogeneity overestimates the effect of treatment delay. Including interaction terms between treatment and starting time of treatment or between treatment and follow up time gave no improvement. Estimating a frailty term can improve the estimation, but is sensitive to misspecification of the frailty distribution. Therefore, multiple frailty distributions should be used and the results should be compared using the Akaike Information Criterion. Non‐parametric estimation of the cumulative recovery percentages can be considered if the dataset contains sufficient long term follow up for each of the delay strategies. The methods are demonstrated on a motivating application evaluating the effect of delaying the start of treatment with assisted reproductive techniques on time‐to‐pregnancy in couples with unexplained subfertility.
format Online
Article
Text
id pubmed-7383985
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-73839852020-07-28 The effect of treatment delay on time‐to‐recovery in the presence of unobserved heterogeneity van Geloven, Nan Balan, Theodor A. Putter, Hein le Cessie, Saskia Biom J Duration and Survival We study the effect of delaying treatment in the presence of (unobserved) heterogeneity. In a homogeneous population and assuming a proportional treatment effect, a treatment delay period will result in notably lower cumulative recovery percentages. We show in theoretical scenarios using frailty models that if the population is heterogeneous, the effect of a delay period is much smaller. This can be explained by the selection process that is induced by the frailty. Patient groups that start treatment later have already undergone more selection. The marginal hazard ratio for the treatment will act differently in such a more homogeneous patient group. We further discuss modeling approaches for estimating the effect of treatment delay in the presence of heterogeneity, and compare their performance in a simulation study. The conventional Cox model that fails to account for heterogeneity overestimates the effect of treatment delay. Including interaction terms between treatment and starting time of treatment or between treatment and follow up time gave no improvement. Estimating a frailty term can improve the estimation, but is sensitive to misspecification of the frailty distribution. Therefore, multiple frailty distributions should be used and the results should be compared using the Akaike Information Criterion. Non‐parametric estimation of the cumulative recovery percentages can be considered if the dataset contains sufficient long term follow up for each of the delay strategies. The methods are demonstrated on a motivating application evaluating the effect of delaying the start of treatment with assisted reproductive techniques on time‐to‐pregnancy in couples with unexplained subfertility. John Wiley and Sons Inc. 2020-01-20 2020-07 /pmc/articles/PMC7383985/ /pubmed/31957043 http://dx.doi.org/10.1002/bimj.201900131 Text en © 2020 The Authors. Biometrical Journal published by WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Duration and Survival
van Geloven, Nan
Balan, Theodor A.
Putter, Hein
le Cessie, Saskia
The effect of treatment delay on time‐to‐recovery in the presence of unobserved heterogeneity
title The effect of treatment delay on time‐to‐recovery in the presence of unobserved heterogeneity
title_full The effect of treatment delay on time‐to‐recovery in the presence of unobserved heterogeneity
title_fullStr The effect of treatment delay on time‐to‐recovery in the presence of unobserved heterogeneity
title_full_unstemmed The effect of treatment delay on time‐to‐recovery in the presence of unobserved heterogeneity
title_short The effect of treatment delay on time‐to‐recovery in the presence of unobserved heterogeneity
title_sort effect of treatment delay on time‐to‐recovery in the presence of unobserved heterogeneity
topic Duration and Survival
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383985/
https://www.ncbi.nlm.nih.gov/pubmed/31957043
http://dx.doi.org/10.1002/bimj.201900131
work_keys_str_mv AT vangelovennan theeffectoftreatmentdelayontimetorecoveryinthepresenceofunobservedheterogeneity
AT balantheodora theeffectoftreatmentdelayontimetorecoveryinthepresenceofunobservedheterogeneity
AT putterhein theeffectoftreatmentdelayontimetorecoveryinthepresenceofunobservedheterogeneity
AT lecessiesaskia theeffectoftreatmentdelayontimetorecoveryinthepresenceofunobservedheterogeneity
AT vangelovennan effectoftreatmentdelayontimetorecoveryinthepresenceofunobservedheterogeneity
AT balantheodora effectoftreatmentdelayontimetorecoveryinthepresenceofunobservedheterogeneity
AT putterhein effectoftreatmentdelayontimetorecoveryinthepresenceofunobservedheterogeneity
AT lecessiesaskia effectoftreatmentdelayontimetorecoveryinthepresenceofunobservedheterogeneity